Correlation Between AVROBIO and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both AVROBIO and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AVROBIO and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AVROBIO and Altamira Therapeutics, you can compare the effects of market volatilities on AVROBIO and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AVROBIO with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AVROBIO and Altamira Therapeutics.
Diversification Opportunities for AVROBIO and Altamira Therapeutics
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between AVROBIO and Altamira is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding AVROBIO and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and AVROBIO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AVROBIO are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of AVROBIO i.e., AVROBIO and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between AVROBIO and Altamira Therapeutics
If you would invest 140.00 in AVROBIO on September 15, 2024 and sell it today you would earn a total of 0.00 from holding AVROBIO or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 1.56% |
Values | Daily Returns |
AVROBIO vs. Altamira Therapeutics
Performance |
Timeline |
AVROBIO |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Altamira Therapeutics |
AVROBIO and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AVROBIO and Altamira Therapeutics
The main advantage of trading using opposite AVROBIO and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AVROBIO position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.AVROBIO vs. Ocean Biomedical | AVROBIO vs. Enveric Biosciences | AVROBIO vs. Elevation Oncology | AVROBIO vs. Zura Bio Limited |
Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |